|
RSPRY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.193700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.007400E-04 |
| Normal-vs-Stage2 |
5.235600E-01 |
| Normal-vs-Stage3 |
3.422600E-01 |
| Normal-vs-Stage4 |
4.268400E-02 |
| Stage1-vs-Stage2 |
2.683200E-01 |
| Stage1-vs-Stage3 |
2.330600E-01 |
| Stage1-vs-Stage4 |
7.296400E-01 |
| Stage2-vs-Stage3 |
9.434200E-01 |
| Stage2-vs-Stage4 |
3.349600E-01 |
| Stage3-vs-Stage4 |
2.892400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.536000E-03 |
| Normal-vs-AfricanAmerican |
6.564700E-04 |
| Normal-vs-Asian |
3.813200E-01 |
| Caucasian-vs-AfricanAmerican |
2.969000E-01 |
| Caucasian-vs-Asian |
9.106400E-01 |
| AfricanAmerican-vs-Asian |
7.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34919999999583E-05 |
| Normal-vs-Female |
5.733600E-01 |
| Male-vs-Female |
6.223500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.198500E-04 |
| Normal-vs-Extreme_Weight |
1.26879999995388E-06 |
| Normal-vs-Obese |
4.326600E-01 |
| Normal-vs-Extreme_Obese |
3.809800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.963400E-01 |
| Normal_Weight-vs-Obese |
3.453600E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.518200E-01 |
| Extreme_Weight-vs-Obese |
5.419700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.144000E-01 |
| Obese-vs-Extreme_Obese |
6.106000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.654400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.970500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.815000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.587600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.404200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.122400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.999200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.122830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.851200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.696400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.8561000000058E-06 |
| Normal-VS-Type2 PRCC |
2.194000E-01 |
| Normal-VS-KIRP CIMP |
9.715200E-01 |
| Normal-VS-Unclassified PRCC |
9.119800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.612000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.099600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.340400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.301400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.878000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.766400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.717300E-03 |
| Normal-vs-N1 |
4.663800E-01 |
| Normal-vs-N2 |
8.286600E-01 |
| N0-vs-N1 |
1.977180E-01 |
| N0-vs-N2 |
5.287400E-01 |
| N1-vs-N2 |
9.769400E-01 |
|
|
